Ropack Expands Capabilities and Establishes US Presence

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-01-06-2016
Volume 12
Issue 1

Ropack Inc. adds R&D, formulation, lab analysis, and manufacturing capabilities in Long Island, NY.

Ropack Inc. has purchased two pharmaceutical facilities in Long Island, New York, adding research and development, formulation, lab analysis, and commercial and clinical manufacturing capabilities to the company’s established solid oral dosage packaging and clinical study distribution offerings.

In addition, the company reported that activities in the United States will be managed through Ropack USA Inc., and that Ropack Inc. and Ropack USA Inc. will now be known as Ropack Pharma Solutions.

The buildings, formerly operated by Forest Laboratories, total 213,700 sq-ft. The company operates four facilities in Montreal, Canada, for the packaging of solid oral dosage in bottles, flip-top vials, blister packs, stick-packs and sachets and is a Canadian clinical trial depot.

Source: Ropack

 

 

Recent Videos
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content